Change History |
|
Main Specialty (Consultant) (AMD) | |
Single Cancer Pathway – Core (AMD) | |
Single Cancer Pathway - Core | |
National Cancer Data Standards for Wales – Core |
This data item is / was included in the following data sets / collections between the dates shown:
Data Set / Collection |
Valid From |
Valid To |
National Cancer Ds - Core |
|
|
SCPC ds |
1st January 2021 |
|
The cancer treatment delivered to the patient.
Format: 2 character alpha-numeric
Value |
Meaning |
01 |
Surgery |
02 |
Anti-Cancer Drug Regimen (Cytotoxic Chemotherapy) |
03 |
Anti-Cancer Drug Regimen (Hormone Therapy) |
04 |
Chemoradiotherapy |
05 |
Teletherapy (Beam Radiation excluding Proton therapy) |
06 |
Brachytherapy |
07 |
Specialist Palliative Care |
08 |
Active Monitoring (excluding Non-Specialist palliative care) |
09 |
Non Specialist Palliative Care (excluding Active monitoring) |
10 |
Radiofrequency Ablation (RFA) |
11 |
High Intensity Focused Ultrasound (HIFU) |
12 |
Cryotherapy |
13 |
Proton Therapy |
14 |
Anti-Cancer Drug Regimen (Other) |
15 |
Anti-Cancer Drug Regimen (Immunotherapy) |
16 |
Light Therapy (including Photodynamic Therapy and Psoralen and Ultraviolet A Therapy (PUVA Therapy)) |
17 |
Hyperbaric Oxygen Therapy |
19 |
Radioisotope Therapy (including Radioiodine) |
20 |
Laser Treatment (including Argon Beam Therapy) |
21 |
Biological Therapies (excluding Immunotherapy) |
22 |
Radiosurgery |
97 |
Other Treatment (not listed) |
98 |
All Treatment Declined |